HbA1c by age and sex is an increasingly important consideration in interpreting blood glucose results accurately. HbA1c — glycated haemoglobin — measures average blood glucose over 8–12 weeks and is the cornerstone test for diagnosing and monitoring diabetes in the UK. Yet results can vary subtly between males and females, and tend to rise gradually with age even in people without diabetes. Understanding how age and sex influence HbA1c values helps clinicians and patients interpret borderline readings more confidently, apply appropriate NICE-aligned targets, and take timely action when results fall outside the normal range.

What Is HbA1c and Why Does It Matter?

HbA1c measures the proportion of glycated haemoglobin in red blood cells, reflecting average blood glucose over 8–12 weeks. A result of 48 mmol/mol or above on two occasions diagnoses type 2 diabetes in asymptomatic adults (NICE NG28).

HbA1c — formally known as glycated haemoglobin — is a blood test that reflects your average blood glucose levels over the preceding 8–12 weeks. When glucose circulates in the bloodstream, it binds to haemoglobin (the protein inside red blood cells that carries oxygen). The higher your blood glucose over time, the greater the proportion of haemoglobin that becomes glycated. Because red blood cells have a lifespan of roughly 120 days, the HbA1c result provides a reliable window into longer-term glucose control, rather than a single snapshot.

The test is expressed as a percentage or, more commonly in the UK, in millimoles per mole (mmol/mol) following the adoption of IFCC (International Federation of Clinical Chemistry) standardisation. For most adults without diabetes, a normal HbA1c sits below 42 mmol/mol (6.0%). Readings between 42–47 mmol/mol (6.0–6.4%) indicate a raised risk of type 2 diabetes — sometimes called non-diabetic hyperglycaemia or prediabetes — whilst a result of 48 mmol/mol (6.5%) or above on two separate occasions is used by NICE to diagnose type 2 diabetes in asymptomatic individuals (NICE NG28; WHO 2011).

Understanding HbA1c is important because persistently elevated blood glucose is associated with serious long-term complications, including:

• Cardiovascular disease (heart attack, stroke)

• Diabetic retinopathy (sight loss)

• Peripheral neuropathy (nerve damage)

• Chronic kidney disease

Early identification through HbA1c testing allows timely lifestyle intervention or medical management, significantly reducing the risk of these complications. Within the NHS Health Check programme (offered to adults aged 40–74), diabetes risk is first assessed using a validated risk tool (such as QDiabetes); HbA1c or fasting plasma glucose testing is then offered only to those identified as being at higher risk, rather than to all attendees.

When HbA1c should not be used to diagnose diabetes

HbA1c is not appropriate for diagnosing diabetes in all situations. Alternative tests — fasting plasma glucose (FPG) or a 75 g oral glucose tolerance test (OGTT) — should be used in the following circumstances:

• Pregnancy (including suspected gestational diabetes)

• Suspected type 1 diabetes in adults or children

• Children and young people (under 18 years)

• Within approximately 2 months of an acute illness, major surgery, or any treatment known to affect red blood cell turnover

• Conditions causing significant haemolysis, haemoglobin variants, or other red-cell disorders

In symptomatic adults, a single raised plasma glucose result is sufficient to diagnose diabetes — treatment should not be delayed whilst awaiting HbA1c confirmation (NICE NG28; WHO 2011).

Differences in HbA1c Levels Between Men and Women

Females may have slightly higher HbA1c values than males at equivalent glucose levels, partly due to iron deficiency anaemia, though the difference is small and NHS diagnostic thresholds remain the same for both sexes.

Research suggests that HbA1c values may differ between males and females, even when blood glucose concentrations are similar. On average, females may have slightly higher HbA1c readings than males at equivalent glucose levels, though the effect sizes reported in studies are generally small and may be partly explained by confounding factors such as iron deficiency anaemia, which is more prevalent in females of reproductive age.

Several biological mechanisms have been proposed — including differences in red blood cell turnover, haemoglobin concentration, and hormonal influences — but these remain hypotheses rather than established facts, and the clinical significance of any sex-related difference at the population level is modest. Clinicians are encouraged to interpret borderline results in the context of the individual patient's full clinical picture.

Age also interacts with sex in potentially relevant ways:

• In younger females, iron deficiency (which is common) can affect HbA1c independently of glucose levels; this should be considered when interpreting borderline results.

• During pregnancy, HbA1c is not used to diagnose gestational diabetes. NICE (NG3) recommends a 75 g OGTT at 24–28 weeks for women at increased risk, as increased red blood cell turnover during pregnancy makes HbA1c unreliable for this purpose.

• Around menopause, changes in insulin sensitivity may contribute to rising HbA1c values in some women, though robust population-level data are limited.

• A gradual increase in HbA1c with age is observed in both males and females without diabetes, partly reflecting changes in red blood cell physiology and declining renal function.

It is important to note that current NHS and NICE diagnostic thresholds do not differ by sex or age — the same cut-off of 48 mmol/mol applies universally. Suspected type 1 diabetes in an adult of any sex should prompt urgent referral to a specialist team within 24 hours, rather than reliance on HbA1c alone (NICE NG17).

NHS and NICE Guidance on HbA1c Targets

NICE recommends an HbA1c target of 48 mmol/mol for most adults with type 2 diabetes on diet or metformin, rising to 53 mmol/mol when hypoglycaemia-risk medications such as sulphonylureas or insulin are used.

NICE provides clear, evidence-based guidance on HbA1c targets for people living with diabetes, recognising that optimal targets must be individualised rather than applied rigidly, and should be reviewed regularly.

For adults with type 2 diabetes managed by lifestyle and diet alone, or with metformin, NICE (NG28) recommends an HbA1c target of 48 mmol/mol (6.5%). Where additional glucose-lowering medications are used that carry a risk of hypoglycaemia — particularly sulphonylureas or insulin — the target is relaxed to 53 mmol/mol (7.0%) to reduce the risk of low blood sugar episodes.

For adults with type 1 diabetes, NICE (NG17) recommends aiming for an HbA1c of 48 mmol/mol (6.5%) or lower if this can be achieved safely without problematic hypoglycaemia. Targets are reviewed regularly and adjusted based on individual circumstances, including age, frailty, comorbidities, and the person's own preferences and quality of life.

Key NICE-aligned HbA1c reference points:

• Below 42 mmol/mol — Normal range (non-diabetic)

• 42–47 mmol/mol — Non-diabetic hyperglycaemia / prediabetes (lifestyle intervention recommended; referral to NHS Diabetes Prevention Programme where eligible)

• 48 mmol/mol or above — Diagnostic threshold for type 2 diabetes (confirmed on repeat testing in asymptomatic individuals)

• 53 mmol/mol — Upper treatment target for people on glucose-lowering therapy carrying a hypoglycaemia risk (e.g., sulphonylureas, insulin)

For older adults, those with frailty, or those with significant comorbidities, NICE and NHS guidance acknowledges that less stringent, individually agreed targets may be appropriate to avoid hypoglycaemia and maintain quality of life. The specific target should be agreed between the person and their clinical team, taking into account the risks and benefits of tighter control. De-intensification of therapy should be considered when targets are no longer appropriate.

HbA1c is not used to diagnose type 1 diabetes, diabetes in children, or gestational diabetes — alternative diagnostic pathways apply in these situations (NICE NG17; NICE NG3).

If you are taking medicines that can cause hypoglycaemia (such as sulphonylureas or insulin) and experience side effects, these can be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.

Factors That Can Affect Your HbA1c Result

Conditions altering red blood cell lifespan — including haemolytic anaemia, iron deficiency, pregnancy, and recent transfusion — can falsely lower or raise HbA1c independently of actual blood glucose control.

While HbA1c is a robust and widely used marker, several physiological and pathological factors can cause the result to be falsely elevated or falsely lowered — independent of actual blood glucose control. Clinicians must be aware of these variables, particularly when results appear inconsistent with a patient's reported symptoms or self-monitored glucose readings.

Conditions that may falsely lower HbA1c:

• Haemolytic anaemia — increased red blood cell destruction shortens their lifespan, reducing glycation time

• Iron deficiency anaemia treated with iron supplementation — rapid production of new red blood cells dilutes the glycated fraction over the following weeks to months

• Pregnancy — increased red blood cell turnover lowers HbA1c independently of glucose levels

• Recent blood transfusion (within approximately 3 months) — transfused red blood cells have not been exposed to the recipient's glucose levels

• Acute blood loss or erythropoietin (ESA) therapy — both stimulate new red blood cell production, shortening average cell age

• Haemoglobin variants (e.g., sickle cell trait, HbS, HbC) — may interfere with certain laboratory assay methods, though many modern IFCC-aligned methods used in UK laboratories have minimal interference; local laboratory guidance should be consulted

Conditions that may falsely raise HbA1c:

• Iron deficiency anaemia (untreated) — older red blood cells accumulate, increasing the proportion available for glycation

• Vitamin B12 or folate deficiency — reduced red blood cell production prolongs average cell lifespan

• Chronic kidney disease — uraemic interference with some assay methods has been described, though the effect is assay-dependent and less pronounced with modern IFCC-aligned methods; the presence of anaemia and ESA use in CKD further complicates interpretation

• Splenectomy or hyposplenism — prolonged red blood cell survival increases glycation time

• Severe liver disease — may affect red blood cell turnover and haemoglobin metabolism

Age itself is associated with a modest rise in HbA1c, even in individuals without diabetes, partly due to changes in red blood cell physiology and declining renal clearance. Ethnicity may also play a role; some studies suggest that people of African-Caribbean or South Asian heritage may have slightly higher HbA1c values at equivalent glucose levels, though the clinical significance of this remains under investigation.

Where HbA1c is considered unreliable, fasting plasma glucose (FPG) or a 75 g oral glucose tolerance test (OGTT) should be used for diagnosis. For ongoing monitoring in situations where HbA1c is unreliable, a clinician may consider alternative markers such as fructosamine or glycated albumin. If you are unsure whether your HbA1c result may be affected by any of these factors, discuss this with your GP or diabetes team (RCPath/Association for Clinical Biochemistry guidance on HbA1c measurement; WHO 2011).

When to Speak to a GP About Your HbA1c Reading

Contact your GP promptly if your HbA1c is 42 mmol/mol or above; seek urgent help if symptoms suggest diabetic ketoacidosis or hypoglycaemia, as these are medical emergencies.

Knowing when to seek medical advice about an HbA1c result is an important aspect of self-care and early disease management. Whether you have received a result through an NHS Health Check, a routine blood test, or a home testing service, understanding the significance of the number — and acting on it promptly — can make a meaningful difference to long-term health outcomes.

Seek urgent medical help (call 999, go to A&E, or call NHS 111) if you or someone else has:

• Marked thirst, frequent urination, and unexplained weight loss together with feeling unwell, abdominal pain, vomiting, drowsiness, confusion, or a fruity smell on the breath — these may be signs of diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS), which are medical emergencies

• Symptoms suggesting very low blood sugar (hypoglycaemia): shakiness, sweating, confusion, or loss of consciousness

You should contact your GP promptly if:

• Your HbA1c result is 42 mmol/mol or above, even if you feel well — this warrants further assessment and may qualify you for the NHS Diabetes Prevention Programme

• You have a result of 48 mmol/mol or above — your GP will arrange a repeat test to confirm a diagnosis of type 2 diabetes in asymptomatic individuals

• You are already diagnosed with diabetes and your HbA1c has risen above your agreed target on two consecutive tests

• You experience symptoms suggestive of high blood glucose — such as increased thirst, frequent urination, unexplained weight loss, or fatigue — regardless of your most recent HbA1c result; in symptomatic adults, diagnosis can be made using a plasma glucose test without waiting for HbA1c

• Symptoms suggest possible type 1 diabetes (often a more rapid onset of symptoms, sometimes with weight loss and ketones in urine) — NICE (NG17) recommends referral to a specialist diabetes team within 24 hours in this situation

• You are pregnant or planning a pregnancy and have a personal or family history of diabetes — the appropriate diagnostic test in pregnancy is an OGTT, not HbA1c (NICE NG3)

• You have a condition known to affect HbA1c reliability (such as haemolytic anaemia, a haemoglobin variant, or recent transfusion) and need an alternative diagnostic test

It is equally important not to interpret a single HbA1c result in isolation. Results should always be discussed with a healthcare professional who can consider your full medical history, current medications, and lifestyle factors.

Home HbA1c testing services are commercially available, and some use accredited laboratories. However, a diagnosis of diabetes should always be confirmed using a venous blood sample analysed by an NHS or accredited laboratory, in line with NHS and WHO guidance. If you are unsure about your result or what it means for your health, your GP practice or a diabetes specialist nurse can provide personalised guidance.

Still have questions? Message our pharmacists for free →

Frequently Asked Questions